1,3-dichloro-2-propanol induced lipid accumulation by blocking autophagy flux in HepG2 cells.


Journal

Toxicology
ISSN: 1879-3185
Titre abrégé: Toxicology
Pays: Ireland
ID NLM: 0361055

Informations de publication

Date de publication:
30 04 2021
Historique:
received: 22 10 2020
revised: 21 01 2021
accepted: 06 02 2021
pubmed: 14 2 2021
medline: 13 5 2021
entrez: 13 2 2021
Statut: ppublish

Résumé

Great attention has been paid to 1,3-dichloro-2-propanol (1,3-DCP) due to its presence in food and concerns about toxic potential as carcinogens. In our previous study, we found that long-term low-dose 1,3-DCP exposure induced lipid accumulation in mouse liver. Recent studies have demonstrated that autophagy plays an important role in regulating lipid metabolism. So, we speculated that 1,3-DCP induced lipid accumulation by regulating autophagy in hepatocytes. In this study, we first studied the effect of 100 μM 1,3-DCP on autophagy flux in HepG2 cells. The data showed that 1,3-DCP (100 μM) impaired autophagy flux mainly through the attenuation of autophagosomes via AKT/mTOR signaling pathway and inhibition of lysosomes biosynthesis. Furthermore, we demonstrated that treatment with 100 μM 1,3-DCP for 24 h affected lipid metabolism through the colocalization of LC3 and Bodipy. We used an autophagy activator or an autophagy inhibitor to test the effect of 1,3-DCP on lipid accumulation through detecting lipid droplets staining, triglyceride (TG) and total cholesterol (TC). The data showed that 1,3-DCP-induced lipid accumulation was alleviated in the presence of Rapamycin (an autophagy activator). On the contrary, 1,3-DCP-induced lipid accumulation was significantly exacerbated in the presence of an autophagy inhibitor (3-methyladenine or chloroquine). These results suggested that 1,3-DCP might induce lipid accumulation by the impairment of autophagy flux in HepG2 cells.

Identifiants

pubmed: 33581215
pii: S0300-483X(21)00039-1
doi: 10.1016/j.tox.2021.152716
pii:
doi:

Substances chimiques

1,3-dichloro-2-propanol 0F4P2VQC07
alpha-Chlorohydrin 96-24-2
MTOR protein, human EC 2.7.1.1
Proto-Oncogene Proteins c-akt EC 2.7.11.1
TOR Serine-Threonine Kinases EC 2.7.11.1

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

152716

Informations de copyright

Copyright © 2021 Elsevier B.V. All rights reserved.

Auteurs

Jing Lu (J)

College of Food Science and Engneering, Jilin University, Changchun, Jilin, 130062, People's Republic of China. Electronic address: lu_jing@jlu.edu.cn.

Yong Fan (Y)

College of Food Science and Engneering, Jilin University, Changchun, Jilin, 130062, People's Republic of China.

Meitong Liu (M)

College of Food Science and Engneering, Jilin University, Changchun, Jilin, 130062, People's Republic of China.

Qian Zhang (Q)

College of Food Science and Engneering, Jilin University, Changchun, Jilin, 130062, People's Republic of China.

Shuang Guan (S)

Key Laboratory of Zoonosis, Ministry of Education College of Veterinary Medicine, Jilin University, Changchun, Jilin, 130062, People's Republic of China; College of Food Science and Engneering, Jilin University, Changchun, Jilin, 130062, People's Republic of China. Electronic address: guan_shuang22@jlu.edu.cn.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH